The Patent Docs of MBHB have created an excellent set of posts on the top biotech and pharma patent stories of 2008:
- Continuation and Claims Rules Enjoined in GSK/Tafas v. Dudas; USPTO Appeals Injunction
- The Rise and Fall of Other USPTO Rules Packages
- Patent Reform Stalls in the Senate
- New Written Description Guidelines Issued
- Examination of Obviousness in Group 1600
- The USPTO Comes under Attack
- Follow-on Biologics Debate Continues
- Impact of Presidential Election on U.S. Patent Practice
- The USPTO Tightens Its Grip on Practitioners
- USPTO’s PTA Calculations Called into Question
- Greater Cooperation between Patent Offices
- International Enforcement of Drug Patents
- Pharma Patent Injunctions in View of Amgen v. F. Hoffmann-La Roche
Read the reviews: